Actively Recruiting
Behavioral Intervention for Youth to Promote Vaping Cessation
Led by Massachusetts General Hospital · Updated on 2025-10-22
400
Participants Needed
1
Research Sites
171 weeks
Total Duration
On this page
Sponsors
M
Massachusetts General Hospital
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study will test the hypothesis that the QuitVaping (QV) intervention and additional texting support will improve nicotine abstinence rates in adolescents as compared to Enhanced Usual Care (EUC: education about nicotine, vaping and addiction, advice to quit vaping, referral to TIQ texting support). Approximately 400 adolescents will be randomly assigned to one of two arms (1) QuitVaping intervention plus texting support to quit vaping and (2) EUC only.
CONDITIONS
Official Title
Behavioral Intervention for Youth to Promote Vaping Cessation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 14-18 inclusive
- Self-report of at least weekly nicotine vaping or use of other non-combusted nicotine products for at least 3 months
- No regular use of smoked tobacco (less than 5 days per week) before enrollment and exhaled CO less than 10 ppm for those with in-person baseline visit
- Willingness to try to quit or reduce vaping in the next 30 days
- Ability to understand study procedures and read and write in English or Spanish
- Have a parent or legal guardian able to participate in the opt-out process
- Competent and willing to provide written informed consent if age 18 or assent if under 18
You will not qualify if you...
- Use of smoking cessation medications in the prior month (nicotine patch, gum, nasal spray, inhaler, varenicline, bupropion)
- Unwillingness to abstain from using smoking cessation aids other than those provided by the study during the study period
- Unwillingness to provide saliva or urine samples
- Any condition or situation that would, in the investigator's opinion, make safe adherence to the study protocol unlikely
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Massachusetts General Hospital, Center for Addiction Medicine, 101 Merrimac Street, Suite 320, Boston, MA 02114
Boston, Massachusetts, United States, 02114
Actively Recruiting
Research Team
A
A. Eden Evins, MD, MPH
CONTACT
J
Julia Jashinski, MSW
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here